Stryker (SYK) Long-Term Investments (2009 - 2010)
Stryker's (SYK) quarterly Long-Term Investments came in at -$110.0 million in Q4 2010, down 170.06% year-on-year from $157.0 million in Q4 2009, and down 170.06% on a QoQ basis from $157.0 million in Q4 2009.
Stryker (SYK) Long-Term Investments (2009 - 2010) Analysis & Trends
Stryker (SYK) has 2 years of Long-Term Investments data on file, last reported at -$110.0 million in Q4 2010.
- On a quarterly basis, Long-Term Investments fell 170.06% year-over-year to -$110.0 million in Q4 2010; TTM through Dec 2010 was -$110.0 million, a 170.06% decrease from a year earlier, with the FY2010 full-year figure at -$110.0 million, down 170.06% from the prior year.
- Long-Term Investments for Q4 2010 stood at -$110.0 million, down from $157.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for SYK reached as high as $157.0 million in Q4 2009 and fell as low as -$110.0 million in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -110.00 Mn |
| Dec 31, 2009 | 157.00 Mn |